Total Payments
$3,668
2022 Payments
$324.53
Companies
27
Transactions
191
Medicare Patients
16,515
Medicare Billing
$760,257
Payment Breakdown by Category
Food & Beverage$3,668 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,668 | 191 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $543.22 | 24 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $506.06 | 28 | $0 (2021) |
| GlaxoSmithKline, LLC. | $416.19 | 18 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $333.95 | 22 | $0 (2022) |
| ABBVIE INC. | $333.36 | 18 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $238.88 | 16 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $195.93 | 9 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $161.57 | 8 | $0 (2022) |
| Amgen Inc. | $144.68 | 7 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $101.74 | 6 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $324.53 | 15 | ABBVIE INC. ($135.78) |
| 2021 | $781.06 | 37 | PFIZER INC. ($256.15) |
| 2020 | $692.68 | 35 | PFIZER INC. ($241.07) |
| 2019 | $659.16 | 34 | AstraZeneca Pharmaceuticals LP ($159.58) |
| 2018 | $556.28 | 34 | AstraZeneca Pharmaceuticals LP ($170.74) |
| 2017 | $654.66 | 36 | GlaxoSmithKline, LLC. ($113.30) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: RESPIRATORY | ||||||
| 08/18/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.32 | General |
| Category: Cardiovascular | ||||||
| 07/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/26/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: RESPIRATORY | ||||||
| 05/12/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $33.33 | General |
| Category: Cardiovascular | ||||||
| 04/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: Cardiovascular | ||||||
| 03/08/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Gastroenterology | ||||||
| 02/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: RESPIRATORY | ||||||
| 12/22/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: Cardiovascular | ||||||
| 12/20/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $40.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $24.57 | General |
| Category: Neurology | ||||||
| 11/17/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.84 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 964 | 1,399 | $505,969 | $111,079 |
| 2022 | 38 | 4,896 | 7,408 | $846,255 | $217,365 |
| 2021 | 37 | 5,121 | 7,847 | $849,110 | $219,956 |
| 2020 | 38 | 5,534 | 8,880 | $862,925 | $211,859 |
Total Patients
16,515
Total Services
25,534
Medicare Billing
$760,257
Procedure Codes
122
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 676 | $357,566 | $73,492 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 59 | $43,892 | $9,613 | 21.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 104 | 104 | $23,755 | $7,481 | 31.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 48 | 48 | $25,719 | $7,026 | 27.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 113 | 113 | $11,752 | $4,066 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 46 | $17,292 | $3,529 | 20.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 112 | 114 | $13,047 | $2,889 | 22.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 196 | 205 | $12,573 | $2,699 | 21.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 32 | 34 | $374.00 | $285.60 | 76.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 257 | 688 | $251,070 | $74,197 | 29.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 219 | 219 | $72,270 | $33,882 | 46.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 50 | 51 | $51,000 | $8,534 | 16.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 286 | 620 | $37,200 | $8,206 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 47 | $20,855 | $7,728 | 37.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 292 | 687 | $34,350 | $7,159 | 20.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 250 | 354 | $23,010 | $5,878 | 25.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 240 | 253 | $30,360 | $5,395 | 17.8% |
| 82306 | Vitamin d-3 level | Office | 2022 | 179 | 182 | $20,020 | $5,328 | 26.6% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2022 | 252 | 354 | $19,470 | $4,962 | 25.5% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 158 | 166 | $38,180 | $4,682 | 12.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 72 | 185 | $11,100 | $3,493 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 49 | $11,270 | $3,456 | 30.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 257 | 277 | $31,855 | $3,261 | 10.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 250 | 355 | $14,200 | $3,157 | 22.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 136 | 313 | $18,780 | $3,006 | 16.0% |
About Dr. William Zarowitz, M.D
Dr. William Zarowitz, M.D is a Internal Medicine healthcare provider based in White Plains, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831161819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Zarowitz, M.D has received a total of $3,668 in payments from pharmaceutical and medical device companies, with $324.53 received in 2022. These payments were reported across 191 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,668).
As a Medicare-enrolled provider, Zarowitz has provided services to 16,515 Medicare beneficiaries, totaling 25,534 services with total Medicare billing of $760,257. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location White Plains, NY
- Active Since 02/03/2006
- Last Updated 10/20/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831161819
Products in Payments
- Livalo (Drug) $333.95
- UBRELVY (Drug) $295.41
- ELIQUIS (Drug) $270.51
- ENTRESTO (Drug) $238.88
- SHINGRIX (Biological) $219.06
- CHANTIX (Drug) $183.61
- XIFAXAN (Drug) $176.01
- SYMBICORT (Drug) $153.95
- FASENRA (Drug) $136.28
- BEVESPI AEROSPHERE (Drug) $116.55
- QULIPTA (Drug) $114.80
- STIOLTO RESPIMAT (Drug) $93.67
- Vascepa (Drug) $91.72
- COLOGUARD (Device) $85.64
- TRELEGY ELLIPTA (Drug) $83.83
- Uloric (Drug) $79.23
- Xofluza (Drug) $66.18
- STIOLTO (Drug) $54.82
- Repatha (Biological) $51.85
- FARXIGA (Drug) $50.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in White Plains
Tomrul Tuzel, M.d, M.D
Internal Medicine — Payments: $113,652
Internal Medicine $113,652
Dr. Sharon Parish, Md, MD
Internal Medicine — Payments: $74,824
Internal Medicine $74,824
Despoina Michailidou, Md, MD
Internal Medicine — Payments: $73,621
Internal Medicine $73,621
Daniel Wang, M.d, M.D
Internal Medicine — Payments: $19,656
Internal Medicine $19,656
Dr. Breta Boots, Do, DO
Internal Medicine — Payments: $9,255
Internal Medicine $9,255
Dr. Vivian Volterre, M.d, M.D
Internal Medicine — Payments: $7,003
Internal Medicine $7,003